{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T14:08:02Z","timestamp":1764079682357,"version":"3.37.3"},"reference-count":25,"publisher":"Japan Epidemiological Association","issue":"2","funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation, Republic of Korea","doi-asserted-by":"crossref","award":["NRF-2020R1C1C1003527"],"award-info":[{"award-number":["NRF-2020R1C1C1003527"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Epidemiology"],"published-print":{"date-parts":[[2023,2,5]]},"DOI":"10.2188\/jea.je20210099","type":"journal-article","created":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T22:09:40Z","timestamp":1622239780000},"page":"82-90","source":"Crossref","is-referenced-by-count":2,"title":["Immeasurable Time Bias in Self-controlled Designs: Case-crossover, Case-time-control, and Case-case-time-control Analyses"],"prefix":"10.2188","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6678-0941","authenticated-orcid":false,"given":"Han Eol","family":"Jeong","sequence":"first","affiliation":[{"name":"School of Pharmacy, Sungkyunkwan University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6556-9984","authenticated-orcid":false,"given":"Hyesung","family":"Lee","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Sungkyunkwan University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9878-4779","authenticated-orcid":false,"given":"In-Sun","family":"Oh","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Sungkyunkwan University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6055-0088","authenticated-orcid":false,"given":"Kristian B.","family":"Filion","sequence":"additional","affiliation":[{"name":"Departments of Medicine and of Epidemiology, Biostatistics, and Occupational Health, McGill University"},{"name":"Centre for Clinical Epidemiology, Lady Davis Research Institute - Jewish General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1010-7525","authenticated-orcid":false,"given":"Ju-Young","family":"Shin","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Sungkyunkwan University"},{"name":"Department of Clinical Research Design &amp; Evaluation, Samsung Advanced Institute for Health Sciences &amp; Technology, Sungkyunkwan University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"991","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Suissa S. Immeasurable time bias in observational studies of drug effects on mortality. <i>Am J Epidemiol<\/i>. 2008;168(3):329\u2013335.","DOI":"10.1093\/aje\/kwn135"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Palmaro A, Boucherie Q, Dupouy J, Micallef J, Lapeyre-Mestre M. Immeasurable time bias due to hospitalization in medico-administrative databases: which impact for pharmacoepidemiological studies? <i>Pharmacoepidemiol Drug Saf<\/i>. 2017;26(5):544\u2013553.","DOI":"10.1002\/pds.4193"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Oh IS, Baek YH, Jeong HE, Filion KB, Shin JY. Analytical approaches to minimizing immeasurable time bias in cohort studies. <i>Int J Epidemiol<\/i>. 2021;50(3):987\u2013999.","DOI":"10.1093\/ije\/dyaa251"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Oh IS, Filion KB, Jeong HE, Shin JY. An empirical assessment of immeasurable time bias in the setting of nested case-control studies: statins and all-cause mortality among patients with heart failure. <i>Pharmacoepidemiol Drug Saf<\/i>. 2019;28(10):1318\u20131327.","DOI":"10.1002\/pds.4888"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Jeong S, Tchoe HJ, Li J, Shin JY. All-cause mortality associated with tramadol use: a case-crossover study. <i>Drug Saf<\/i>. 2019;42(6):785\u2013796.","DOI":"10.1007\/s40264-018-00786-y"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Tolppanen AM, Koponen M, Tanskanen A, et\u00a0al. Antipsychotic use and risk of hospitalization or death due to pneumonia in persons with and those without Alzheimer disease. <i>Chest<\/i>. Dec 2016;150(6):1233\u20131241.","DOI":"10.1016\/j.chest.2016.06.004"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Gislason GH, Rasmussen JN, Abildstrom SZ, et\u00a0al. Increased mortality and cardiovascular morbidity associated with use of nonsteroidal anti-inflammatory drugs in chronic heart failure. <i>Arch Intern Med<\/i>. 2009;169(2):141\u2013149.","DOI":"10.1001\/archinternmed.2008.525"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Corrao G, Zambon A, Faini S, Bagnardi V, Leoni O, Suissa S. Short-acting inhaled beta-2-agonists increased the mortality from chronic obstructive pulmonary disease in observational designs. <i>J Clin Epidemiol<\/i>. 2005;58(1):92\u201397.","DOI":"10.1016\/j.jclinepi.2004.04.013"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Maclure M. Case-crossover designs for more patient-centred epidemiology. <i>Paediatr Perinat Epidemiol<\/i>. Mar 2014;28(2):77\u201378.","DOI":"10.1111\/ppe.12107"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Consiglio GP, Burden AM, Maclure M, McCarthy L, Cadarette SM. Case-crossover study design in pharmacoepidemiology: systematic review and recommendations. <i>Pharmacoepidemiol Drug Saf<\/i>. Nov 2013;22(11):1146\u20131153.","DOI":"10.1002\/pds.3508"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Greenland S. Confounding and exposure trends in case-crossover and case-time-control designs. <i>Epidemiology<\/i>. 1996;7(3):231\u2013239.","DOI":"10.1097\/00001648-199605000-00003"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Maclure M. The case-crossover design: a method for studying transient effects on the risk of acute events. <i>Am J Epidemiol<\/i>. 1991;133:144\u2013153.","DOI":"10.1093\/oxfordjournals.aje.a115853"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Suissa S. The case-time-control design. <i>Epidemiology<\/i>. 1995;6(3):248\u2013253.","DOI":"10.1097\/00001648-199505000-00010"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Wang S, Linkletter C, Maclure M, et\u00a0al. Future cases as present controls to adjust for exposure trend bias in case-only studies. <i>Epidemiology<\/i>. 2011;22(4):568\u2013574.","DOI":"10.1097\/EDE.0b013e31821d09cd"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Lee J, Lee JS, Park SH, Shin SA, Kim K. Cohort Profile: The National Health Insurance Service-National Sample Cohort (NHIS-NSC), South Korea. <i>Int J Epidemiol<\/i>. 2017;46(2):e15.","DOI":"10.1093\/ije\/dyv319"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Kim YY, Park JH, Kang HJ, Lee EJ, Ha S, Shin SA. Level of agreement and factors associated with discrepancies between nationwide medical history questionnaires and hospital claims data. <i>J Prev Med Public Health<\/i>. 2017;50(5):294\u2013302.","DOI":"10.3961\/jpmph.17.024"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Poly TN, Islam MM, Yang HC, Li YJ. Association between benzodiazepines use and risk of hip fracture in the elderly people: a meta-analysis of observational studies. <i>Joint Bone Spine<\/i>. 2020;87(3):241\u2013249.","DOI":"10.1016\/j.jbspin.2019.11.003"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Donnelly K, Bracchi R, Hewitt J, Routledge PA, Carter B. Benzodiazepines, Z-drugs and the risk of hip fracture: A systematic review and meta-analysis. <i>PLoS One<\/i>. 2017;12(4):e0174730.","DOI":"10.1371\/journal.pone.0174730"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Yang BR, Oh IS, Li J, Jeon HL, Shin JY. Association between opioid analgesic plus benzodiazepine use and death: a case-crossover study. <i>J Psychosom Res<\/i>. 2020;135:110153.","DOI":"10.1016\/j.jpsychores.2020.110153"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Parsaik AK, Mascarenhas SS, Khosh-Chashm D, et\u00a0al. Mortality associated with anxiolytic and hypnotic drugs-a systematic review and meta-analysis. <i>Aust N Z J Psychiatry<\/i>. 2016;50(6):520\u2013533.","DOI":"10.1177\/0004867415616695"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Langholz B, Goldstein L. Risk set sampling in epidemiologic cohort studies. <i>Stat Sci<\/i>. 1996;11(1):35\u201353.","DOI":"10.1214\/ss\/1032209663"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Wang SV, Gagne JJ, Glynn RJ, Schneeweiss S. Case-crossover studies of therapeutics: design approaches to addressing time-varying prognosis in elderly populations. <i>Epidemiology<\/i>. 2013;24(3):375\u2013378.","DOI":"10.1097\/EDE.0b013e31828ac9cb"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Glynn RJ, Knight EL, Levin R, Avorn J. Paradoxical relations of drug treatment with mortality in older persons. <i>Epidemiology<\/i>. 2001;12(6):682\u2013689.","DOI":"10.1097\/00001648-200111000-00017"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Patrick AR, Shrank WH, Glynn RJ, et\u00a0al. The association between statin use and outcomes potentially attributable to an unhealthy lifestyle in older adults. <i>Value Health<\/i>. 2011;14(4):513\u2013520.","DOI":"10.1016\/j.jval.2010.10.033"},{"key":"25","unstructured":"25. Health Insurance Review and Assessment Service. <i>Evaluation and consideration methods of consistency between health insurance claims diagnostic codes and medical records<\/i>. 2017."}],"container-title":["Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jea\/33\/2\/33_JE20210099\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T04:24:29Z","timestamp":1715315069000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jea\/33\/2\/33_JE20210099\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,5]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.2188\/jea.je20210099","relation":{},"ISSN":["0917-5040","1349-9092"],"issn-type":[{"type":"print","value":"0917-5040"},{"type":"electronic","value":"1349-9092"}],"subject":[],"published":{"date-parts":[[2023,2,5]]},"article-number":"JE20210099"}}